Event Newsletter

Tubulis GmbH

  • Bioscience
Butenandtstraße 1
Munich 81377
+49 89 218074233

About Us

Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic read more
  • About

    Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and will collaborate with partners to usher in a new ADC era and deliver better outcomes for patients.

  • Highlights

    • Antibody Drug Conjugates
    • Targeted Therapy
    • Oncology